Company logo

KYMR - Kymera Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
Watertown, United States
Type: Equity

KYMR price evolution
KYMR
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $115.78 $86.84 $58.19 $56.3
Short term investments $264.92 $276.77 $315.19 $346.73
Net receivables $15 $3.78 $4.12 $3.32
Inventory
Total current assets $405.32 $375.69 $385.4 $411.55
Long term investments $61.43 $76.99 $104.76 $119.02
Property, plant & equipment $101.08 $91.1 $83.18 $74.04
Goodwill & intangible assets
Total noncurrent assets $170.44 $176.68 $196.54 $202.35
Total investments $326.35 $353.76 $419.95 $465.74
Total assets $575.76 $552.38 $581.95 $613.9
Current liabilities
Accounts payable $7.08 $4.98 $3.75 $6.48
Deferred revenue $54.65 $43.77 $44.72 $57.11
Short long term debt $6.34 $3.6 $3.8 $3.89
Total current liabilities $85.69 $63.17 $54.6 $61.93
Long term debt $78.33 $77.25 $71.26 $64.86
Total noncurrent liabilities $95.1 $93.68 $91.92 $89.97
Total debt $84.67 $80.84 $75.06 $68.76
Total liabilities $180.79 $156.84 $146.52 $151.9
Shareholders' equity
Retained earnings -$530.75 -$516.38 -$463.52 -$424.72
Other shareholder equity -$0.55 -$2.45 -$3.63 -$3.04
Total shareholder equity $394.97 $395.54 $435.43 $462
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $115.78 $74.53 $54.09 $32.59
Short term investments $264.92 $338.77 $394.44 $265.2
Net receivables $15 $2.54 $0.14 $0.58
Inventory
Total current assets $405.32 $419.42 $451.27 $302.34
Long term investments $61.43 $152.33 $125.19 $162.53
Property, plant & equipment $101.08 $22.24 $21.31 $20.69
Goodwill & intangible assets
Total noncurrent assets $170.44 $183.72 $154.63 $184.84
Total investments $326.35 $491.1 $519.63 $427.73
Total assets $575.76 $603.13 $605.9 $487.18
Current liabilities
Accounts payable $7.08 $4.33 $4 $4.37
Deferred revenue $54.65 $63.26 $101.03 $170.39
Short long term debt $6.34 $3.94 $3.6 $3.26
Total current liabilities $85.69 $71.34 $92.54 $110.62
Long term debt $78.33 $1.25 $14.36 $14.73
Total noncurrent liabilities $95.1 $41.64 $53.73 $92.67
Total debt $84.67 $17.34 $17.96 $17.99
Total liabilities $180.79 $112.98 $146.27 $203.29
Shareholders' equity
Retained earnings -$530.75 -$383.79 -$228.98 -$128.76
Other shareholder equity -$0.55 -$4.95 -$0.66 -$0.13
Total shareholder equity $394.97 $490.15 $459.64 $283.89
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $47.88
Cost of revenue
Gross Profit $47.88
Operating activities
Research & development $52.97 $48.12 $45.77 $42.23
Selling, general & administrative $14.23 $14.12 $14.13 $12.56
Total operating expenses $67.2 $62.24 $59.9 $54.79
Operating income -$19.31 -$62.24 -$59.9 -$54.79
Income from continuing operations
EBIT -$14.32 -$52.83 -$38.75 -$40.87
Income tax expense
Interest expense $0.05 $0.04 $0.05 $0.06
Net income
Net income -$14.37 -$52.87 -$38.8 -$40.93
Income (for common shares) -$14.37 -$52.87 -$38.8 -$40.93
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $78.59 $34.03
Cost of revenue
Gross Profit $78.59 $34.03
Operating activities
Research & development $189.08 $164.25 $137.02 $62.1
Selling, general & administrative $55.04 $43.83 $36.34 $18.23
Total operating expenses $244.12 $208.08 $173.36 $80.34
Operating income -$165.53 -$208.08 -$173.36 -$46.3
Income from continuing operations
EBIT -$146.77 -$154.63 -$100.04 -$45.48
Income tax expense
Interest expense $0.2 $0.18 $0.17 $0.12
Net income
Net income -$146.96 -$154.81 -$100.22 -$45.59
Income (for common shares) -$146.96 -$154.81 -$100.22 -$45.59
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$14.37 -$52.87 -$38.8 -$40.93
Operating activities
Depreciation $0.89 $0.9 $0.9 $0.88
Business acquisitions & disposals
Stock-based compensation $10.9 $11.65 $11.18 $9.38
Total cash flows from operations $8.04 -$31.65 -$35.26 -$43.97
Investing activities
Capital expenditures -$11.63 -$8.08 -$10.77 -$4.01
Investments $30.58 $68.59 $46.61 $28.59
Total cash flows from investing $18.95 $60.51 $35.84 $24.58
Financing activities
Dividends paid
Sale and purchase of stock $1.01 $0.13 $1.64 $1.49
Net borrowings $0.93 -$0.34 -$0.33 -$0.33
Total cash flows from financing $1.93 -$0.21 $1.3 $1.16
Effect of exchange rate
Change in cash and equivalents $28.93 $28.66 $1.89 -$18.23
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$146.96 -$154.81 -$100.22 -$45.59
Operating activities
Depreciation $3.56 $2.98 $2.4 $1.76
Business acquisitions & disposals
Stock-based compensation $43.12 $35.48 $24.97 $5.19
Total cash flows from operations -$102.83 -$153.09 -$128.95 $88.13
Investing activities
Capital expenditures -$34.48 -$2.84 -$1.6 -$9.1
Investments $174.37 $23.36 -$98.24 -$413.49
Total cash flows from investing $139.89 $20.52 -$99.83 -$422.59
Financing activities
Dividends paid
Sale and purchase of stock $4.27 $154.13 $251.13 $196.84
Net borrowings -$0.08 -$1.13 -$0.85 -$0.55
Total cash flows from financing $4.19 $153 $250.28 $289.26
Effect of exchange rate
Change in cash and equivalents $41.25 $20.43 $21.5 -$45.2
Fundamentals
Market cap $2.23B
Enterprise value $2.20B
Shares outstanding 55.59M
Revenue $47.88M
EBITDA -$143.20M
EBIT -$146.77M
Net Income -$146.96M
Revenue Q/Q InfinityT%
Revenue Y/Y N/A
P/E ratio -15.19
EV/Sales 45.98
EV/EBITDA -15.38
EV/EBIT -15.00
P/S ratio 46.63
P/B ratio 5.65
Book/Share 7.12
Cash/Share 2.08
EPS -$2.64
ROA -25.29%
ROE -34.83%
Debt/Equity 0.46
Net debt/EBITDA -0.45
Current ratio 4.73
Quick ratio 4.73